MICRO THERAPEUTICS, INC. DBA EV3

Manufacturer adverse-event records for MICRO THERAPEUTICS, INC. DBA EV3 come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2016–2026 · mid-book · elevated Death-code · balanced

Death-code intensity

MICRO THERAPEUTICS, INC. DBA EV3 carries an elevated Death-code share

Death-coded event_type rows are 1,172 of 15,560 (7.53% · elevated tercile among 434 manufacturers). Absolute volume is mid-book.

What the Death-code reading shows for MICRO THERAPEUTICS, INC. DBA EV3

The standout signal for MICRO THERAPEUTICS, INC. DBA EV3 is Death-code intensity: 7.53% of 15,560 reports (elevated tercile), while absolute volume is mid-book.

Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for MICRO THERAPEUTICS, INC. DBA EV3. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.

Reports span 20 device types, led in this extract by Malfunction at 10,182 (65.4% of event_type total). Peak single-year volume reaches 2,764 reports across 11 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

15,560
Total Reports
1,172
Event-type Death
4,206
Injury Reports
20
Device Types

Event Types

Malfunction 10,182 (65.4%)
Injury 4,206 (27.0%)
Death 1,172 (7.5%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

9,732 (58.7%)
Required Intervention 1,811 (10.9%)
Other 1,488 (9.0%)
Death 1,028 (6.2%)
Hospitalization 516 (3.1%)
R 498 (3.0%)
Life Threatening 320 (1.9%)
Disability 240 (1.4%)
H 235 (1.4%)
L 214 (1.3%)
S 181 (1.1%)
O 161 (1.0%)
D 154 (0.9%)
Congenital Anomaly 1 (0.0%)

Yearly Trend

16
2016: 3
17
2017: 7
18
2018: 37
19
2019: 1,117
20
2020: 1,355
21
2021: 1,658
22
2022: 2,189
23
2023: 2,571
24
2024: 2,543
25
2025: 2,764
26
2026: 1,316